首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1477275

癌症治疗市场，按治疗类型，按癌症类型，按地理位置

Cancer Therapy Market, By Therapy Type, By Cancer Type, By Geography

出版日期: 2024年04月12日 | 出版商:

Coherent Market Insights | 英文 174 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年癌症治疗市场价值为2,051亿美元，预计到2031年将达到4,662.1亿美元，2024年至2031年的年复合成长率（CAGR）为12.4%。

报告范围		报告详情
基准年：	2023年	2024 年市场规模：	2051亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测 2024 年至 2031 年复合年增长率：	12.40%	2031 年价值预测：	4662.1 亿美元

图 1. 2024 年癌症治疗市占率 (%)（按地区）

癌症持续为全世界的医疗保健带来重大挑战。许多国家的人口迅速老化导致癌症盛行率上升。此外，环境污染水平的增加和生活方式的改变，如不健康的饮食、缺乏体力活动、吸烟和饮酒，增加了人群患癌症的风险。儘管治疗干预措施取得了进步，但癌症死亡率仍然很高。因此，肿瘤学领域的药物开发活动近年来有所加强，重点是改善患者的治疗结果和生活品质。

市场动态：

癌症治疗市场受到多种因素的推动，例如生活方式的改变导致全球癌症盛行率不断上升、老年人口不断增长、标靶治疗和个人化医疗的日益采用、新兴国家医疗保健基础设施的扩张以及癌症研发投资的增加由製药公司。然而，与癌症护理相关的高治疗成本限制了广泛采用。此外，新药审批週期长也在一定程度上对市场成长构成挑战。同时，强大的癌症临床试验管道和生物相似药的进入为预测期内的市场扩张提供了重大机会。

研究的主要特点：

该报告对全球癌症治疗市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数描述了全球癌症治疗市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球癌症治疗市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球癌症治疗市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
东协
澳洲
韩国
亚太地区其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
北非
中非
南非

第 8 章：竞争格局

公司简介
- Bristol-Myers Squibb Company
- AstraZeneca
- Pfizer Inc.
- Novartis AG
- GSK plc.
- Sanofi
- Bayer AG
- Amgen Inc.
- Gilead Sciences, Inc.
- Boehringer Ingelheim International GmbH.
- ADC Therapeutics SA
- F. Hoffmann-La Roche Ltd
- Merck & Co., Inc.
- Eureka Therapeutics, Inc.
- AbbVie Inc.
- Fate Therapeutics
- Sorrento Therapeutics, Inc.
- Carrick Therapeutics Limited
- Atara Biotherapeutics, Inc.
- Celluris
- NeoTX
- Kazia Therapeutics Limited

第 9 章：分析师观点

命运之轮
分析师观点
连贯的机会图

第 10 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI5335

The cancer therapy market is estimated to be valued at USD 205.10 Bn in 2024 and is expected to reach USD 466.21 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 205.10 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	12.40%	2031 Value Projection:	US$ 466.21 Bn

Figure 1.Cancer Therapy Market Share (%), By Region, 2024

Cancer continues to pose significant healthcare challenges worldwide. Rapidly aging population profiles in numerous countries have contributed to the rising cancer prevalence. Furthermore, increasing environmental pollution levels and lifestyle changes such as unhealthy diets, lack of physical activity, tobacco use, and alcohol consumption have elevated the cancer risk in populations. Despite advancements in therapeutic interventions, cancer mortality remains substantial. As a result, drug development activity in the oncology sector has intensified in recent times focused on improving patient outcomes and quality of life.

Market Dynamics:

The cancer therapy market is driven by various factors such as the increasing prevalence of cancer worldwide owing to changing lifestyle patterns, growing geriatric population, increasing adoption of targeted therapies and personalized medicine, expansion of healthcare infrastructure across emerging nations, and rising investment in cancer R&D by pharmaceutical companies. However, high treatment costs associated with cancer care pose limitations to widespread adoption. Moreover, long regulatory approval timelines for new drug approvals also challenge market growth to some extent. Meanwhile, robust cancer clinical trial pipelines and the entry of biosimilars provide significant opportunities for market expansion over the forecast period.

Key Features of the Study:

This report provides an in-depth analysis of the global cancer therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cancer therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Novartis AG, GSK plc., Sanofi, Bayer AG, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH., ADC Therapeutics SA, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Eureka Therapeutics, Inc., AbbVie Inc., Fate Therapeutics, Sorrento Therapeutics, Inc., Carrick Therapeutics Limited, Atara Biotherapeutics, Inc., Celluris, NeoTX, and Kazia Therapeutics Limited.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global cancer therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer therapy market.

Detailed Segmentation-

Therapy Type:
- Chemotherapy
- Alkylating agents
- Antimetabolites
- Anti-tumor antibiotics
- Others
- Target Therapy
- Monoclonal antibodies
- Small molecule inhibitors
- Others
- Immunotherapy
- Immune Checkpoint Inhibitors
- Oncolytic virus therapy
- T-cell therapy
- Radiotherapy
- Others
Cancer Type:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Blood Cancer
- Liver Cancer
- Thyroid Cancer
- Head and Neck Cancer
- Skin Cancer
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AstraZeneca
- Pfizer Inc.
- Novartis AG
- GSK plc.
- Sanofi
- Bayer AG
- Amgen Inc.
- Gilead Sciences, Inc.
- Boehringer Ingelheim International GmbH.
- ADC Therapeutics SA
- Hoffmann-La Roche Ltd
- Merck & Co., Inc.
- Eureka Therapeutics, Inc.
- AbbVie Inc.
- Fate Therapeutics
- Sorrento Therapeutics, Inc.
- Carrick Therapeutics Limited
- Atara Biotherapeutics, Inc.
- Celluris
- NeoTX
- Kazia Therapeutics Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Cancer Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Acquisitions and Partnerships Scenario
Reimbursement Scenario
Epidemiology
Treatment Algorithm (Patient Journey)
Cancer Diagnosis and Treatment Options
Pipeline Analysis
Patient Advocacy and Empowerment
Regulatory Scenario
Pricing Analysis
PEST Analysis
PORTER's Analysis

4. Global Cancer Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 impact on the market

5. Global Cancer Therapy Market, By Therapy Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Alkylating agents
Antimetabolites
Anti-tumor antibiotics
Others
Target Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Monoclonal antibodies
Small molecule inhibitors
Others
Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immune Checkpoint Inhibitors
Oncolytic virus therapy
T-cell therapy
Radiotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Cancer Therapy Market, By Cancer Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Breast Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Lung Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Colorectal Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Prostate Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Blood Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Liver Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Thyroid Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Head and Neck Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Skin Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Cancer Therapy Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Company Profiles
- Bristol-Myers Squibb Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- AstraZeneca
- Pfizer Inc.
- Novartis AG
- GSK plc.
- Sanofi
- Bayer AG
- Amgen Inc.
- Gilead Sciences, Inc.
- Boehringer Ingelheim International GmbH.
- ADC Therapeutics SA
- F. Hoffmann-La Roche Ltd
- Merck & Co., Inc.
- Eureka Therapeutics, Inc.
- AbbVie Inc.
- Fate Therapeutics
- Sorrento Therapeutics, Inc.
- Carrick Therapeutics Limited
- Atara Biotherapeutics, Inc.
- Celluris
- NeoTX
- Kazia Therapeutics Limited